Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec
NCT00879242
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Beta Thalassemia Transfusion Dependent
Interventions
DRUG:
Deferasirox
Sponsor
Novartis Pharmaceuticals